Literature DB >> 16006667

Mild cognitive impairment (MCI) represents early-stage Alzheimer's disease.

John C Morris1, Jeffrey Cummings.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16006667     DOI： 10.3233/jad-2005-7306

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN： 1387-2877            Impact factor:   4.472


× No keyword cloud information.
  44 in total

1.  Voxel Level Survival Analysis of Grey Matter Volume and Incident Mild Cognitive Impairment or Alzheimer's Disease.

Authors:  Lubov E Zeifman; William F Eddy; Oscar L Lopez; Lewis H Kuller; Cyrus Raji; Paul M Thompson; James T Becker
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

2.  Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease.

Authors:  D Allan Butterfield; Tanea T Reed; Marzia Perluigi; Carlo De Marco; Raffaella Coccia; Jeffrey N Keller; William R Markesbery; Rukhsana Sultana
Journal:  Brain Res       Date:  2007-03-07       Impact factor: 3.252

3.  Detecting biological heterogeneity patterns in ADNI amnestic mild cognitive impairment based on volumetric MRI.

Authors:  Ali Ezzati; Andrea R Zammit; Christian Habeck; Charles B Hall; Richard B Lipton
Journal:  Brain Imaging Behav       Date:  2020-10       Impact factor: 3.978

4.  Rate of entorhinal and hippocampal atrophy in incipient and mild AD: relation to memory function.

Authors:  T R Stoub; E J Rogalski; S Leurgans; D A Bennett; L deToledo-Morrell
Journal:  Neurobiol Aging       Date:  2008-09-21       Impact factor: 4.673

5.  Caloric intake, aging, and mild cognitive impairment: a population-based study.

Authors:  Yonas E Geda; Marion Ragossnig; Lewis A Roberts; Rosebud O Roberts; V Shane Pankratz; Teresa J H Christianson; Michelle M Mielke; James A Levine; Bradley F Boeve; Ondřej Sochor; Eric G Tangalos; David S Knopman; Ronald C Petersen
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

6.  Retinal alterations in mild cognitive impairment and Alzheimer's disease: an optical coherence tomography study.

Authors:  Francisco J Ascaso; Nancy Cruz; Pedro J Modrego; Raul Lopez-Anton; Javier Santabárbara; Luis F Pascual; Antonio Lobo; José A Cristóbal
Journal:  J Neurol       Date:  2014-05-21       Impact factor: 4.849

Review 7.  The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation.

Authors:  Eugenio Barone; Fabio Di Domenico; Cesare Mancuso; D Allan Butterfield
Journal:  Neurobiol Dis       Date:  2013-10-02       Impact factor: 5.996

Review 8.  Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment.

Authors:  Rukhsana Sultana; D Allan Butterfield
Journal:  J Bioenerg Biomembr       Date:  2009-10       Impact factor: 2.945

Review 9.  Exosomal miRNAs in central nervous system diseases: biomarkers, pathological mediators, protective factors and therapeutic agents.

Authors:  Xiaohuan Xia; Yi Wang; Yunlong Huang; Han Zhang; Hongfang Lu; Jialin C Zheng
Journal:  Prog Neurobiol       Date:  2019-09-19       Impact factor: 11.685

10.  Abnormal cortical networks in mild cognitive impairment and Alzheimer's disease.

Authors:  Zhijun Yao; Yuanchao Zhang; Lei Lin; Yuan Zhou; Cunlu Xu; Tianzi Jiang
Journal:  PLoS Comput Biol       Date:  2010-11-18       Impact factor: 4.475
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.